Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIMICS trial of continuous wound infiltration after minimally invasive colorectal surgery
NL-OMON58633Phase 3Recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain and Postoperative recovery after colorectal surgery comparing Continuous wound infiltration with bupivacaine with Placebo continuous wound infiltration (2 arms). Primary endpoint: Postoperative recovery. Started Oct 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painPostoperative recovery after colorectal surgery
Beyond the preview
Go deeper on NL-OMON58633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58633.